11Background: NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis) are emerging conditions that sequentially affect hepatocyte metabolism. Fibroblast Growth Factor 21 (FGF21) is produced by the liver and has autocrine and paracrine actions on liver energy metabolism while serpinB3 (SCCA) is produced by damaged liver cells and is considered a marker of progression to cirrhosis and hepatocellular carcinoma. Aim of the study: A first aim of this study is to investigate expression profile of FGF21 and its receptor/coreceptor in liver biopsies of patients with NAFLD and NASH. A second aim is to assess whether circulating concentration of SCCA-IgM is increased in patients with NASH compared to patients with pure fat...
AbstractFibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in...
Objective: Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseas...
Fibroblast growth factor 21 (FGF21) is an adipokine and hepatokine, and its hepatic expression is in...
Background & Aims: Fibroblast growth factor 21 (FGF21), a hormone primarily secreted by the liver in...
Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in the We...
Fibroblast growth factor 21 (FGF21) is a peptide hormone predominantly secreted by the liver and pla...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwi...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwid...
P>Background The fibroblast growth factor 21 (FGF21) hormonal pathway is a metabolic signalling casc...
Nonalcoholic fatty liver disease (NAFLD) is a common cause of hepatic abnormalities worldwide. Nonal...
Fibroblast growth factor 21 (Fgf21) has emerged as a potential plasma marker to diagnose non-alcohol...
<div><p>Atypical fibroblast growth factors (FGF) 21 and 19 play a central role in energy metabolism ...
Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world ...
Background & aimsNon-alcoholic steatohepatitis (NASH), a subtype of non-alcoholic fatty liver diseas...
Objectives: We sought to determine whether serum concentrations of fibroblast growth factor 19 (FGF1...
AbstractFibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in...
Objective: Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseas...
Fibroblast growth factor 21 (FGF21) is an adipokine and hepatokine, and its hepatic expression is in...
Background & Aims: Fibroblast growth factor 21 (FGF21), a hormone primarily secreted by the liver in...
Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in the We...
Fibroblast growth factor 21 (FGF21) is a peptide hormone predominantly secreted by the liver and pla...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwi...
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwid...
P>Background The fibroblast growth factor 21 (FGF21) hormonal pathway is a metabolic signalling casc...
Nonalcoholic fatty liver disease (NAFLD) is a common cause of hepatic abnormalities worldwide. Nonal...
Fibroblast growth factor 21 (Fgf21) has emerged as a potential plasma marker to diagnose non-alcohol...
<div><p>Atypical fibroblast growth factors (FGF) 21 and 19 play a central role in energy metabolism ...
Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the Western world ...
Background & aimsNon-alcoholic steatohepatitis (NASH), a subtype of non-alcoholic fatty liver diseas...
Objectives: We sought to determine whether serum concentrations of fibroblast growth factor 19 (FGF1...
AbstractFibroblast growth factor 21 (FGF21) is a modulator of energy homeostasis and is increased in...
Objective: Non-alcoholic fatty liver (NAFL) associated with obesity is a major cause of liver diseas...
Fibroblast growth factor 21 (FGF21) is an adipokine and hepatokine, and its hepatic expression is in...